Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma

Figure 1

Aberrant miRNAs in the microarray and identification of serum exosomes. (a) Expression of miRNAs selected from previous exosome microarray results. (b) Exosomes of MM patients’ serum purified by the kit method and verified by electron microscopy with scale bar of (A) 1 μm, (B) 200 nm, (C) 100 nm, and (D) 50 nm. (c) Exosomes were verified by Western blotting. The exosomal marker TSG101 is enriched in the extraction.

(a)

(b)

(c)